Design/methodology/approach – A qualitative data collection, using in-depth interviews with representatives of organizations that deal directly with improving the quality of the business environment for biotech industry in India, as well as biotech entrepreneurs and leaders were undertaken. A total of ...
Many cases of HCC in China are often secondary to HCV and HBV infection, the latter of which is of epidemic proportion in China. A therapy for the treatment of HCC is, therefore, of particular relevance to the domestic population. Table 1 Chinese health biotech firms interviewed and their ...
2,159 items Companies in the agtech space, such as equipment manufacturers, surveying drones, geospatial intelligence firms, and farm management platforms G Game Changers 2018 70 items 498 Seventh Avenue 12th floorNew York, NY 10018info@cbinsights.com212 292 3148 About About Us Upcoming Webinars...
So you will talk to a number of psychiatry firms that are taking all sorts of different approaches, but fundamentally, data, the ability to parse huge amounts of data, the increasing availability of some longitudinal data sets in psychiatry—this is going to be critical to the future of ...
Balancing growth and innovation in Indian biotech firms Purpose – Biotech companies are generally faced with the paradoxes of simultaneously managing growth and innovation, as well as addressing explorative and... SE Khilji,T Mroczkowski,R Assudani - 《South Asian Journal of Global Business Research...
The United States has a dominant position in the market, with 48.2% of the firms in the industry operating out of the U.S. Firms in the Asia Pacific area hold 24% of the market, followed by Europe (18.1%), then the Middle East (1.8%)—the rest of the world closes up the remainin...
Dezan Shira & Associates has offices in,Indonesia,Singapore,United States,Germany,Italy,India, andRussia, in addition to our trade research facilities along theBelt & Road Initiative.We also have partner firms assisting foreign investors inThe Philippines,Malaysia,Thailand,Bangladesh....
study of India’s private health biotech sector published in April 2007, opening a window on the product development capabilities and strategies used in rapidly growing economies to survive and grow amid developing country challenges. It also recommends policies that could help their biotech firms ...
BIO also represents academic centers, state and regional biotech associations and service providers to the industry, including financial and consulting firms. 66% R&D-Intensive Companies *Of those: 89% have annual revenues under $25 million, 4% have annual revenues between $25 million and $1 bill...
TPG Biotech is a team of investors enthused by the challenge of translating discoveries and insights in the biomedical sciences into tangible products. Use the CB Insights Platform to explore TPG Biotech's full profile.